Determination of the Minimal Detectable Change of the Parkinson's Disease Questionnaire-8
ConditionParkinson Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age40-80
SponsorEmre Şenocak
About this trial
This study is conducted to determine how many units of improvement the Parkinson's Disease Questionnaire-8 (PDQ-8), used to evaluate the quality of life of Parkinson's patients, should have to express a significant change in the quality of life. Patients for whom a 30-session physiotherapy program is recommended will be included in the study. Patients will be asked to express the change in their quality of life at the end of treatment. The PDQ-8 survey and Global Rating of Patient-Perceived Changes (GRP-PC) forms will be used to determine these changes. Evaluations will be repeated at the beginning of the treatment program and at the end of the 30th session.
Eligibility criteria
Qualifiers
Having regular neurology follow-up and using medicine;
Hoehn and Yahr Scale Stage between 1-3 points;
Mini-Mental State Assessment Score >24 points;
Disqualifiers
Having a secondary neurological disease;
Any surgery and/or trauma affecting the upper extremity
Having complaints of pain before the treatment program;
There was a change in medical treatment during the study;
Trial design
Treatments tested in this trial
- Rehabilitation
Treatment groups
39 Participants
are divided into 1 treatment groupSponsors and collaborators
Emre Şenocak
Lead sponsor
Karadeniz Technical University
Sponsor institution
Source ClinicalTrials.gov